Andon Health Co., Ltd. (SHE:002432)
China · Delayed Price · Currency is CNY 52.10
+0.10 (0.19%)
Oct 28, 2026, 11:45 AM CST
Andon Health Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 21,859 | 16,812 | 18,817 | 17,604 | 23,314 | 23,126 | |
Market Cap Growth | 29.15% | -10.65% | 6.89% | -24.49% | 0.81% | 478.91% |
Enterprise Value | 21,077 | 7,418 | 9,126 | 9,961 | 10,988 | 22,177 |
Last Close Price | 52.00 | 39.19 | 39.70 | 36.41 | 46.34 | 44.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 5.01 | 7.42 | 11.28 | 14.07 | 1.45 | 25.45 |
Forward PE | - | 41.17 | 41.17 | 41.86 | 23.66 | 165.57 |
PS Ratio | 19.28 | 12.31 | 7.26 | 5.45 | 0.89 | 9.65 |
PB Ratio | 0.94 | 0.76 | 0.88 | 0.89 | 1.16 | 8.15 |
P/TBV Ratio | 0.95 | 0.77 | 0.91 | 0.92 | 1.21 | 9.25 |
P/FCF Ratio | - | - | 20.61 | 11.30 | 1.30 | 103.86 |
P/OCF Ratio | - | - | 19.07 | 9.95 | 1.28 | 78.90 |
PEG Ratio | - | 0.13 | 0.13 | 0.13 | 0.61 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 18.59 | 5.43 | 3.52 | 3.08 | 0.42 | 9.25 |
EV/EBITDA Ratio | - | - | 12.49 | 12.02 | 0.59 | 22.51 |
EV/EBIT Ratio | - | - | 13.48 | 13.24 | 0.59 | 24.12 |
EV/FCF Ratio | - | - | 10.00 | 6.40 | 0.61 | 99.60 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.36 | 0.26 | 0.16 | 0.08 | 0.02 | 0.13 |
Debt / EBITDA Ratio | - | - | 4.52 | 1.84 | 0.02 | 0.38 |
Debt / FCF Ratio | - | - | 3.68 | 1.01 | 0.02 | 1.71 |
Net Debt / Equity Ratio | -0.04 | -0.27 | -0.48 | -0.49 | -0.57 | -0.34 |
Net Debt / EBITDA Ratio | 3.93 | 19.82 | -14.06 | -11.83 | -0.62 | -0.98 |
Net Debt / FCF Ratio | 1.66 | 13.67 | -11.26 | -6.30 | -0.63 | -4.33 |
Asset Turnover | 0.04 | 0.05 | 0.11 | 0.15 | 2.05 | 0.75 |
Inventory Turnover | 2.41 | 2.47 | 3.12 | 2.60 | 8.34 | 1.95 |
Quick Ratio | 1.35 | 2.59 | 5.39 | 7.66 | 15.26 | 2.04 |
Current Ratio | 1.39 | 2.65 | 5.50 | 7.90 | 16.52 | 2.75 |
Return on Equity (ROE) | 19.50% | 10.43% | 8.71% | 6.77% | 144.21% | 40.12% |
Return on Assets (ROA) | -0.54% | -0.73% | 1.73% | 2.12% | 90.12% | 17.99% |
Return on Invested Capital (ROIC) | -1.24% | -2.13% | 5.45% | 6.91% | 319.52% | 60.01% |
Return on Capital Employed (ROCE) | -1.00% | -1.30% | 2.80% | 3.60% | 88.40% | 31.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 19.95% | 13.48% | 8.87% | 7.11% | 68.76% | 3.93% |
FCF Yield | -2.69% | -2.56% | 4.85% | 8.85% | 77.25% | 0.96% |
Dividend Yield | 3.17% | 4.11% | 0.49% | 0.79% | 5.05% | 1.38% |
Payout Ratio | 13.65% | 8.25% | 11.43% | 94.81% | 2.01% | 4.04% |
Buyback Yield / Dilution | 3.31% | 1.38% | 2.49% | 3.23% | -2.82% | -5.02% |
Total Shareholder Return | 6.44% | 5.48% | 2.98% | 4.01% | 2.23% | -3.64% |